Heart affected by amyloidosis – a case study (RCD code: III-3A.2)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 5
Abstract
We present a case of a 65-year old woman, who was admitted to hospital due to recurrent pulmonary oedema. Patient's history included chronic obstructive pulmonary disease. Echocardiography revealed a concentric hypertrophy of the left ventricle walls without the narrowing of the outflow tract, accompanied by the mild/moderate mitral stenosis, preserved systolic and mildly impaired diastolic function of the left ventricle. Those comorbidities were not severe but their coexistence contributed to rapid heart failure progression. During another admission for pulmonary oedema the patient had cardiac arrest in the mechanism of the pulseless electrical activity, which triggered the diagnostics of amyloidosis. Right heart catheterization was performed showing an unusually high wedge pressure. Histological analysis confirmed the diagnosis of amyloid light-chain (AL) amyloidosis, so the patient was scheduled for the first course of chemotherapy. Unfortunately, shortly after discharge, the patient developed pulmonary oedema and died before an admission to the hospital. This case shows the adverse course of the disease, fast progression of unspecific symptoms that may attribute to multiple comorbidities. JRCD 2015; 2 (5): 156–160
Authors and Affiliations
Katarzyna Ptaszyńska-Kopczyńska, Włodzimierz Musiał, Karol Kamiński
Keywords
Related Articles
- EP ID EP248045
- DOI 10.20418/jrcd.vol2no5.201
- Views 105
- Downloads 0
A rare cause of the left ventricular outflow tract obstruction: accessory mitral valve tissue (RCD code: IV-1D.2o)
Accessory mitral valve tissue is a rare congenital malformation, which often causes left ventricular outflow tract (LVOT) obstruction. Patients with accessory MVT and LVOT obstruction have poor exercise tolerance, fatigu...
Biventricular cardiomyopathy improvement by shifting therapy from agalsidase alfa to agalsidase beta in Anderson‐Fabry Disease
Treatment of Fabry disease has improved since the introduction of enzyme replacement therapy (ERT). Two preparations of the recom‐ binant enzyme α‐galactosidase A are available: agalsidase alfa and agalsidase beta. We ai...
Pregnancy in pulmonary arterial hypertension (RCD code: VII‑II‑1)
Pulmonary arterial hypertension (PAH) is a progressive disease leading to right ventricular failure and death, if not treated adequately. Pregnancy in women with PAH is associated with significantly high mortality, thus...
JRCD is now an open‑access journal and also accepts high‑quality papers beyond the field of rare cardiovascular diseases and disorders
n/a
Myocardial infarction in Fabry disease – misfortune or companion? Case report and review of the literature
We discuss a 56‑year‑old man with Fabry disease (FD), a genetic X‑linked glycolipid storage disorder. The patient presented at the Emergency Room in a local hospital due to tachycardia‑associated chest pain, which had oc...